Department of Surgical Oncology, Graduate School of Medicine, Tokyo Medical and Dental University, Yushima Bunkyo-ku, Tokyo, Japan.
Surg Endosc. 2013 Feb;27(2):462-70. doi: 10.1007/s00464-012-2459-1. Epub 2012 Aug 14.
The use of laparoscopy-assisted distal gastrectomy (LADG) in advanced gastric cancer (AGC) remains a controversial topic, mainly because of doubts about its oncologic validity. To date, literature on the prognosis for AGC after LADG is scarce. This study evaluated the procedure's long-term benefits compared with those of the conventional, open distal gastrectomy (ODG).
This study involved 201 patients, 66 of whom underwent LADG, with a mean follow-up period of 49.2 months, from January 1999 to March 2010. A clear set of criteria was used to select patients (including no evidence of lymph node metastasis) and surgeons (subject to their experience). Survival outcomes were assessed by Kaplan-Meier analysis and log-rank testing. The postoperative recovery and complications of the patients also were monitored.
No significant difference was observed between LADG and ODG in terms of overall survival or disease-specific survival. The corresponding 5-year survival rates for individual tumor node metastasis stages also were comparable in each group. The number of lymph nodes harvested was similar in the two groups, although the operation time was significantly shorter for ODG. The postoperative hospital stay was shorter for LADG patients (average stay of 8.4 vs. 18.1 days in the ODG group; p < 0.001), and the postoperative complication rate was almost half that for ODG (13.6 vs. 25.0 %; p = 0.048).
The combination of the long- and short-term data indicates that LADG should be considered as a feasible alternative to ODG for the treatment of AGC. Its widespread integration requires the accumulation of similar results across multiple centers worldwide.
腹腔镜辅助远端胃切除术(LADG)在晚期胃癌(AGC)中的应用仍然存在争议,主要是因为对其肿瘤学有效性存在疑问。迄今为止,关于 LADG 后 AGC 预后的文献很少。本研究评估了与传统开腹远端胃切除术(ODG)相比,该手术的长期益处。
本研究纳入了 201 例患者,其中 66 例行 LADG,平均随访时间为 49.2 个月,从 1999 年 1 月至 2010 年 3 月。采用明确的标准选择患者(包括无淋巴结转移证据)和外科医生(取决于他们的经验)。采用 Kaplan-Meier 分析和对数秩检验评估生存结果。还监测了患者的术后恢复和并发症。
在总生存率或疾病特异性生存率方面,LADG 与 ODG 之间无显著差异。各组各肿瘤淋巴结转移分期的 5 年生存率也相当。两组淋巴结清扫数量相似,尽管 ODG 的手术时间明显缩短。LADG 患者的术后住院时间较短(平均住院时间为 8.4 天,ODG 组为 18.1 天;p <0.001),术后并发症发生率几乎为 ODG 的一半(13.6% vs. 25.0%;p = 0.048)。
长期和短期数据的结合表明,LADG 应被视为治疗 AGC 的 ODG 的可行替代方案。其广泛应用需要在全球多个中心积累类似的结果。